Skip to content
Tenfell
Awarded contract
Published 25 Mar 2019

NHS Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B

NHS England · London

Key facts

Awarded
15 Feb 2019
Contract starts
01 Mar 2019
Contract ends
28 Feb 2021
Procedure
Open procedure (above threshold)
Buyer type
Central government

Awarded to 5 suppliers

SupplierValue
Pfizer Ltd—
Novo Nordisk—
CSL Behring UK Ltd—
Swedish Orphan Biovitrum Ltd (Sobi Ltd),.,.,.,.,.,.,.,.,.,.,.,—
Shire Pharmaceuticals Limited—

Description

NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B. The framework will commence on 1st March 2019 for a period of 24 months until 28th February 2021, with options to extend up to a further 24 month.

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.